Intravenous Fosfomycin for the treatment of hospitalized patients with serious infections.

about

Intravenous Fosfomycin for the treatment of hospitalized patients with serious infections.

Item

http://www.wikidata.org/entity/Q40049542

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Intravenous Fosfomycin for the ...... ients with serious infections.

@en

type

Item

label

Intravenous Fosfomycin for the ...... ients with serious infections.

@en

prefLabel

Intravenous Fosfomycin for the ...... ients with serious infections.

@en

P1476

Intravenous Fosfomycin for the ...... ients with serious infections.

@en

P2093

Andrew F Shorr

http://www.w3.org/2001/XMLSchema#string

Jason M Pogue

http://www.w3.org/2001/XMLSchema#string

John F Mohr

http://www.w3.org/2001/XMLSchema#string

P2860

Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa

Community-acquired necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a Chinese teenager: case report and literature review

APACHE II: a severity of disease classification system

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report

Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections.

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Nosocomial infections in the intensive care unit: Incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India.

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.

P31

scholarly article

P356

10.1080/14787210.2017.1379897

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28901793

http://www.w3.org/2001/XMLSchema#string